Improving the ablastic capacity of intravitreal chemotherapy for retinoblastoma
Background: Intravitreally (IV) administered cytostatics are believed to be a promising local chemotherapy for retinoblastoma (RB) because this approach enables the highest level of chemotherapeutic agent after its direct injection into the ocular cavity. Intravitreal administration is, however, inv...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ukrainian Society of Ophthalmologists
2022-04-01
|
| Series: | Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://www.ozhurnal.com/en/archive/2022/2/4-fulltext |